Micardis Hct



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 62.8%
Diabetes Mellitus 4.9%
Blood Cholesterol Increased 4.8%
Prophylaxis 2.9%
Pain 2.6%
Blood Pressure Increased 2.5%
Essential Hypertension 2.5%
Blood Pressure 2.3%
Device Related Infection 1.8%
Gastrooesophageal Reflux Disease 1.6%
Hypothyroidism 1.6%
Asthma 1.5%
Chronic Obstructive Pulmonary Disease 1.4%
Depression 1.4%
Cardiac Disorder 1.1%
Osteoporosis 1.1%
Arthritis 1.0%
Back Pain 1.0%
Drug Use For Unknown Indication 0.7%
Blood Cholesterol 0.6%
Blood Pressure Increased 9.6%
Rash 9.6%
Drug Ineffective 7.5%
Dizziness 6.3%
Vomiting 5.9%
Hypertension 5.4%
Hypertensive Crisis 5.0%
Weight Decreased 5.0%
Hyponatraemia 4.6%
Vision Blurred 4.6%
Weight Increased 4.6%
Pollakiuria 4.2%
Renal Failure Acute 4.2%
Alopecia 3.8%
Hypotension 3.8%
Tinnitus 3.8%
Myocardial Infarction 3.3%
Blood Pressure Inadequately Controlled 2.9%
Cerebrovascular Accident 2.9%
Death 2.9%
Secondary
Hypertension 54.7%
Diabetes Mellitus 7.1%
Gastrooesophageal Reflux Disease 4.8%
Chronic Obstructive Pulmonary Disease 4.3%
Atrial Fibrillation 2.8%
Blood Cholesterol Increased 2.8%
Type 2 Diabetes Mellitus 2.8%
Asthma 2.6%
Hyperlipidaemia 2.0%
Arthritis 1.7%
Cardiac Disorder 1.7%
Prophylaxis 1.7%
Blood Pressure 1.4%
Depression 1.4%
Essential Hypertension 1.4%
Hypothyroidism 1.4%
Neuralgia 1.4%
Pain 1.4%
Acute Coronary Syndrome 1.1%
Back Pain 1.1%
Renal Failure Acute 14.9%
Dyspnoea 7.5%
Hypertensive Crisis 6.0%
Hypotension 6.0%
Muscle Spasms 6.0%
Thrombocytopenia 6.0%
Hypertension 4.5%
Hyponatraemia 4.5%
Myocardial Infarction 4.5%
Oedema Peripheral 4.5%
Palpitations 4.5%
Tremor 4.5%
Vomiting 4.5%
Weight Increased 4.5%
Alopecia 3.0%
Blood Pressure Inadequately Controlled 3.0%
Blood Pressure Increased 3.0%
Coma 3.0%
Dizziness 3.0%
Drug Ineffective 3.0%
Concomitant
Product Used For Unknown Indication 26.7%
Hypertension 21.4%
Drug Use For Unknown Indication 11.8%
Diabetes Mellitus 5.2%
Rheumatoid Arthritis 4.5%
Type 2 Diabetes Mellitus 4.1%
Pain 3.6%
Prophylaxis 3.4%
Blood Cholesterol Increased 2.5%
Atrial Fibrillation 2.4%
Gastrooesophageal Reflux Disease 2.3%
Osteoporosis 1.8%
Depression 1.6%
Osteoarthritis 1.4%
Carcinoid Tumour Pulmonary 1.3%
Diffuse Large B-cell Lymphoma 1.3%
Renal Cell Carcinoma 1.3%
Back Pain 1.2%
Hypersensitivity 1.1%
Metastatic Renal Cell Carcinoma 1.1%
Weight Decreased 14.9%
Myocardial Infarction 6.8%
Pulmonary Embolism 6.4%
Vomiting 6.4%
Syncope 5.5%
Dizziness 5.1%
Nausea 5.1%
Pneumonia 5.1%
Urinary Tract Infection 5.1%
Paraesthesia 4.3%
Pruritus 4.3%
Weight Increased 4.3%
Hypertension 3.8%
Cerebrovascular Accident 3.4%
Death 3.4%
Interstitial Lung Disease 3.4%
Pain 3.4%
Vertigo 3.4%
Blood Glucose Increased 3.0%
Fatigue 3.0%
Interacting
Hypertension 37.5%
Ischaemic Cardiomyopathy 18.8%
Thrombosis Prophylaxis 18.8%
Cardiovascular Event Prophylaxis 12.5%
Hyperuricaemia 6.3%
Type 2 Diabetes Mellitus 6.3%
Renal Failure Acute 75.0%
Hypotension 25.0%